Nucleic Acid Therapeutics Market to Reach USD 22.04 Bn by 2032 with A Growth Rate of 6.6%
Market Overview The Nucleic Acid Therapeutics Market was valued at US$ 5.64 billion in 2024 and is projected to reach US$ 14.42 billion by 2032, registering a CAGR of 10.9% throughout the forecast period 2025–2032. The Nucleic Acid Therapeutics Market explodes with gene-targeting innovations like ASOs and mRNA, tackling cancers and genetic disorders via RNA interference. R&D surges...
0 Comentários 0 Compartilhamentos 154 Visualizações 0 Anterior
Patrocinado